{
    "title": "Novo Nordisk sees slower 2020 growth with U.S. insulin prices pressured",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7968529/Novo-Nordisk-sees-slower-growth-year-vs-2019.html",
    "date": "2020-02-05",
    "keywords": [
        "year",
        "insulin",
        "market",
        "company",
        "profit",
        "jacob",
        "copenhagen",
        "drug",
        "maker",
        "business",
        "pressure",
        "operating",
        "officer",
        "call",
        "launch",
        "rybelsus",
        "result",
        "gronholtpedersen",
        "novo",
        "nordisk",
        "wednesday",
        "pace",
        "pricing",
        "comparison",
        "performance",
        "jorgensen",
        "conference",
        "pill",
        "start",
        "treatment",
        "ozempic",
        "half",
        "companys",
        "revenue",
        "environment",
        "munk",
        "knudsen",
        "noting",
        "middle",
        "transformation",
        "type",
        "hormone",
        "production",
        "obesity",
        "growth",
        "fourthquarter",
        "quarter",
        "forecast",
        "line",
        "guidance",
        "deviate",
        "analyst",
        "gmt",
        "stock",
        "onethird",
        "value",
        "august",
        "himani",
        "sarkar",
        "subhranshu",
        "sahu",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}